Under construction – not a live service
Sign in
Taking people in SpainNo phase

Asks Healthy Adults About Preferred Colorectal Cancer Screening Methods

Asks adults aged 50 to 69 without symptoms about their screening experience and preferences.

Plain-language title generated from the registry record
Registry title: Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Key facts

Where
Madrid, SpainSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 50 to 69 who were invited to the colorectal cancer screening programme and can take the stool test (FOBT) at a Primary Health Care Center. They answer two questionnaires about their screening experience and preferences.

Age
50 to 69 years, both included
Sex
Everyone can join, men and women.
Earlier treatment
People must not have had a colonoscopy because of a positive FOBT result.

Main reasons for not taking part

  • Has not handed in a stool sample at the Primary Health Care Center before signing consent
  • Had a colonoscopy after a positive FOBT result
  • Has a dependent personal or non-medical relationship with the Sponsor or the Investigators

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 69 years old?

Source: NCT06696534, who can take part

Where in Spain

  • CS Mar BálticoMadrid, SpainContact: Maria A Perez, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
ADVANCED MARKER DISCOVERY S.L.
Trial code
NCT06696534
Record updated
2 October 2025
Original description
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:Read full original descriptionShow less

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

* Values of experience of participants into screening programme. * Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Inclusion: Participants ages from 50 to 69 years (both included) at the time of informed consent signed; Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center; Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion: Participants with a previous colonoscopy in consequence of a FOBT positive result; Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form; Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

ClinicalTrials.gov NCT06696534